12:00 AM
 | 
Sep 20, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Fluzone intradermal influenza virus vaccine regulatory update

sanofi's Sanofi Pasteur S.A. vaccines division said FDA accepted for review an sBLA...

Read the full 53 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >